NO20022867L - Syklopentenonderivater - Google Patents
SyklopentenonderivaterInfo
- Publication number
- NO20022867L NO20022867L NO20022867A NO20022867A NO20022867L NO 20022867 L NO20022867 L NO 20022867L NO 20022867 A NO20022867 A NO 20022867A NO 20022867 A NO20022867 A NO 20022867A NO 20022867 L NO20022867 L NO 20022867L
- Authority
- NO
- Norway
- Prior art keywords
- syklopentenonderivater
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
- C07C69/40—Succinic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/80—Phthalic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9929702.0A GB9929702D0 (en) | 1999-12-16 | 1999-12-16 | Chemical compounds and their uses |
PCT/GB2000/004868 WO2001044254A1 (en) | 1999-12-16 | 2000-12-18 | Cyclopenteneone derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022867D0 NO20022867D0 (no) | 2002-06-14 |
NO20022867L true NO20022867L (no) | 2002-08-12 |
Family
ID=10866408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022867A NO20022867L (no) | 1999-12-16 | 2002-06-14 | Syklopentenonderivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030186941A1 (no) |
EP (1) | EP1240171A1 (no) |
JP (1) | JP2003516995A (no) |
KR (1) | KR20020062349A (no) |
CN (1) | CN1409715A (no) |
AU (1) | AU2202401A (no) |
CA (1) | CA2393972A1 (no) |
GB (1) | GB9929702D0 (no) |
HK (1) | HK1048638A1 (no) |
IL (1) | IL150132A0 (no) |
NO (1) | NO20022867L (no) |
WO (1) | WO2001044254A1 (no) |
ZA (1) | ZA200204458B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005511775A (ja) * | 2001-12-14 | 2005-04-28 | チャーターハウス セラピューティックス リミテッド | 医薬組成物の改良 |
EP1456214A2 (en) * | 2001-12-14 | 2004-09-15 | Charterhouse Therapeutics Limited | Improvements in pharmaceutical compositions |
GB0218260D0 (en) * | 2002-08-06 | 2002-09-11 | Charterhouse Therapeutics Ltd | Improvements in pharmaceutically useful compounds |
GB0218261D0 (en) * | 2002-08-06 | 2002-09-11 | Charterhouse Therapeutics Ltd | Improvements in pharmaceutically useful compounds |
EP2802329A2 (en) | 2012-01-09 | 2014-11-19 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Methods of treating or preventing insulin resistance and associated diseases and conditions |
JP6255031B2 (ja) | 2012-11-15 | 2017-12-27 | アメリカ合衆国 | Hiv及びhtlvに感染した患者を治療する方法 |
JP2016533329A (ja) * | 2013-09-25 | 2016-10-27 | ウィリアム マーシュ ライス ユニバーシティWilliam Marsh Rice University | Δ12−pgj3および関連化合物の合成 |
CN106518643B (zh) * | 2016-10-14 | 2019-02-15 | 宁波大学 | 一种环戊烯酮类化合物及其制备方法和用途 |
CN106966886B (zh) * | 2017-01-24 | 2020-06-16 | 宁波大学 | 一种环戊烯酮类化合物及其制备方法和应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954519A (en) * | 1987-04-28 | 1990-09-04 | Georgia Tech Research Corporation | Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents |
DE3586085D1 (de) * | 1984-10-22 | 1992-06-25 | Teijin Ltd | Antitumor-4-hydroxy-2-zyklopentenonen. |
JPS61205230A (ja) * | 1985-03-09 | 1986-09-11 | Nippon Iyakuhin Kogyo Kk | アルキリデンシクロペンテノン誘導体及びその製法 |
JPS6244A (ja) * | 1985-06-25 | 1987-01-06 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
JPS62114933A (ja) * | 1985-11-13 | 1987-05-26 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
JPS62129245A (ja) * | 1985-11-30 | 1987-06-11 | Nippon Iyakuhin Kogyo Kk | 2−ハロ−2−シクロペンテノン誘導体及びその製法 |
US6150090A (en) * | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
AU615534B2 (en) * | 1988-04-19 | 1991-10-03 | Teijin Limited | 2-substituted-2-cyclopentenones |
US5216183A (en) * | 1988-04-19 | 1993-06-01 | Teijin Limited | Cyclopentanone/cyclopentenone derivative |
US5338844A (en) * | 1989-10-19 | 1994-08-16 | Teijin Limited | 2-substituted-2-cyclopentenone compound and anticancer agent and bone formation accelerator comprising same as active ingredient |
CA2144313C (en) * | 1992-09-10 | 1999-03-30 | Minoru Furuya | 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same |
GB9418762D0 (en) * | 1994-09-16 | 1994-11-02 | Bayer Ag | Use of substituted cyclopentane-DI-and-triones |
IT1289250B1 (it) * | 1996-12-13 | 1998-09-29 | Consiglio Nazionale Ricerche | Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb |
IT1284853B1 (it) * | 1996-06-18 | 1998-05-22 | Consiglio Nazionale Ricerche | Impiego del 2-ciclopenten-1-one come induttore di hsp70. |
EA002969B1 (ru) * | 1996-09-27 | 2002-12-26 | Такара Сузо Ко., Лтд. | Антибактериальное средство и антисептик, средство для чистки зубов, косметическое средство, средство для ванн, пищевой продукт или напиток на его основе |
CN100391940C (zh) * | 1997-03-05 | 2008-06-04 | 宝生物工程株式会社 | 化合物 |
EP0976717B1 (en) * | 1997-03-11 | 2002-11-20 | Takara Shuzo Co, Ltd. | Cyclopentenone derivatives |
EA001763B1 (ru) * | 1997-03-28 | 2001-08-27 | Такара Сузо Ко., Лтд. | Терапевтическое средство против сахарного диабета |
US6284801B1 (en) * | 1997-04-01 | 2001-09-04 | Takara Shuzo Co., Ltd. | Antirheumatic agents |
ES2209139T3 (es) * | 1997-06-30 | 2004-06-16 | Takara Bio Inc. | Derivados de ciclopentenona. |
-
1999
- 1999-12-16 GB GBGB9929702.0A patent/GB9929702D0/en not_active Ceased
-
2000
- 2000-12-18 US US10/168,036 patent/US20030186941A1/en not_active Abandoned
- 2000-12-18 EP EP00985616A patent/EP1240171A1/en not_active Withdrawn
- 2000-12-18 CN CN00817160A patent/CN1409715A/zh active Pending
- 2000-12-18 CA CA002393972A patent/CA2393972A1/en not_active Abandoned
- 2000-12-18 WO PCT/GB2000/004868 patent/WO2001044254A1/en not_active Application Discontinuation
- 2000-12-18 JP JP2001544744A patent/JP2003516995A/ja not_active Withdrawn
- 2000-12-18 KR KR1020027007791A patent/KR20020062349A/ko not_active Application Discontinuation
- 2000-12-18 AU AU22024/01A patent/AU2202401A/en not_active Abandoned
- 2000-12-18 IL IL15013200A patent/IL150132A0/xx unknown
-
2002
- 2002-06-04 ZA ZA200204458A patent/ZA200204458B/en unknown
- 2002-06-14 NO NO20022867A patent/NO20022867L/no not_active Application Discontinuation
- 2002-11-06 HK HK02108074.0A patent/HK1048638A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2202401A (en) | 2001-06-25 |
IL150132A0 (en) | 2002-12-01 |
NO20022867D0 (no) | 2002-06-14 |
HK1048638A1 (zh) | 2003-04-11 |
CA2393972A1 (en) | 2001-06-21 |
WO2001044254A1 (en) | 2001-06-21 |
CN1409715A (zh) | 2003-04-09 |
US20030186941A1 (en) | 2003-10-02 |
GB9929702D0 (en) | 2000-02-09 |
KR20020062349A (ko) | 2002-07-25 |
ZA200204458B (en) | 2003-04-17 |
JP2003516995A (ja) | 2003-05-20 |
EP1240171A1 (en) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50010505D1 (de) | Gurtaufrollersystem | |
DE122007000064I1 (de) | Erythropoietinkonjugate | |
DE19983871T1 (de) | Fönvorrichtung | |
DE10084676T1 (de) | Einmallanzettvorrichtung | |
DE50002834D1 (de) | Handstempel | |
ATE357433T1 (de) | 4-pyrimidinyl-n-acyl-l-phenylanine | |
ATE297895T1 (de) | 4-pyridinyl-n-acyl-l-phenylalanine | |
DE50015451D1 (de) | Spülwannensystem | |
DE50009570D1 (de) | Wechselcorrugator | |
DE50007953D1 (de) | Beleuchtungsanordung | |
DE50008613D1 (de) | Sicherungsring | |
DE50000805D1 (de) | Aufsitzspanner | |
DE50006899D1 (de) | Antistatikum | |
DE10085008T1 (de) | Oberflächenbehandlungsdüse | |
DE50003660D1 (de) | Diacylhydrazinderivate | |
DE50012482D1 (de) | Tibiamarknagel | |
NO20022867L (no) | Syklopentenonderivater | |
DE50003259D1 (de) | Textilie | |
DE50006013D1 (de) | Anschlagpuffer | |
DE19983890T1 (de) | Ventiltaktgebungsjustiereinrichtung | |
DE50008429D1 (de) | Kraftstofffraktioniereinrichtung | |
DE50001640D1 (de) | Nahfeldoptische untersuchungsvorrichtung | |
DE50006759D1 (de) | Piperidinalkohole | |
DE50009208D1 (de) | Hydroxyphenylvinylthiazole | |
DE50006829D1 (de) | Benzoylpyridazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |